Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercus robur allergen extract is a biological allergen extract derived from the pollen of Quercus robur (English oak), developed by Inmunotek. It is formulated as a solution for skin prick testing to diagnose IgE-mediated type I hypersensitivity reactions to English oak pollen. The extract is being evaluated in clinical trials to determine its in vivo allergenic potency in histamine equivalent prick (HEP) units, establishing it as a standardized in-house reference preparation (IHRP) for the diagnosis of pollen allergy, allergic rhinitis, allergic rhinoconjunctivitis, and allergic asthma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Quercus robur allergen extract.